PATENT CLAIM ANALYSIS

Application Number: 15954561
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["536", "024500"]

Abstract:
Subjects of the invention are: nucleic acid molecule, expression cassette, expression vector, eukaryotic host cell, induction method of RNA interference in eukaryotic host and use of nucleic acid molecule in therapy of diseases induced by expansion of trinucleotide CAG-type repeats. Solution relates to the new concept of treating hereditary human neurological diseases caused by expansion of CAG-type trinucleotide repeats using RNA interference technology.

Claim (Index 2):
Molecule according to  claim 1 , characterised in that duplex region is 19-30 base pairs long.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 91.0
- Lexical Diversity: 1.59091
- Patent Class: 536.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14916039', '13920969', '12963793', '12774019', '15395993']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6301879217907802
- 35 USC 102 Novelty (BERT): 0.6156527477834117
- Combined Prediction Score: 0.6287344043900434
- Mean Citation Score: 445.839682
- Max Citation Score: 608.9454
- Similarity Product: 480.5657405500173

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test